More importantly, previous studies have reported that heterozygous mutation in PIK3R1 lead to activated phosphoinositide 3-kinase delta syndrome (APDS), which is a primary immunodeficiency and immune dysregulation (Nunes-Santos et al., 2019). This evidence concerns the gene PIK3R1 and activated PI3K-delta syndrome.